Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended March 31, 2024

☐ Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Commission File Number: 333-174194

GRAPHENE & SOLAR TECHNOLOGIES LTD

(Exact name of registrant as specified in its charter)

colorado		27-2888719
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

11201 North Tatum Blvd., Suite 300

Phoenix, AZ 85028

(Address of principal executive offices, including Zip Code)

(602) 388-8335

(Issuer’s telephone number, including area code)

(Former name or former address if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No ☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated Filer	☐	Accelerated Filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 23, 2024, the registrant had 425,792,610 outstanding shares of common stock.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

FORM 10-Q

TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Balance Sheets (Unaudited)	1
Item 2.	Condensed Consolidated Statements of Operations (Unaudited)	2
Item 3.	Condensed Consolidated Statements of Changes in Stockholders’ Deficiency (Unaudited)	3
Item 4.	Condensed Consolidated Statements of Cash Flows (Unaudited)	4
Item 5.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	10
Item 6.	Controls and Procedures.	14

PART II — OTHER INFORMATION
Item 1	Legal Proceedings	16
Item 1A	Risk Factors	16
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 3	Defaults on Senior Securities	16
Item 4	Mine Safety Disclosures	16
Item 5	Other Information	16
Item 6.	Exhibits.	16

SIGNATURES		17

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED BALANCE SHEETS


	March 31, 2024			September 30,
	(Unaudited)			2023
Assets
Current Assets:
Cash	$	1,520		$	1,094
Prepaid expenses		11,235			11,108
Total Current Assets		12,755			12,202
Other Assets:
Furniture and equipment, net of depreciation $78,106		780			937
Intellectual property – at cost, net		1			1
Other intangible assets – at cost		975			975
Other receivable		—			4,015
Total Assets	$	14,511		$	18,130

Liabilities and Stockholders’ Deficit
Current Liabilities:
Accounts payable and other payable	$	2,782,472		$	2,594,247
Accrued interest payable		200,298			184,851
Due to related party		2,376,580			1,985,601
Notes payable, $60,000 in default		60,000			60,000
Notes payable – related party		53,543			71,713
Convertible notes payable, $100,747 in default		100,747			100,747
Convertible notes payable – related party, net of discount $13,895 and $0		63,933			—
Total Current Liabilities		5,637,573			4,997,159

Total Liabilities	$	5,637,573		$	4,997,159

Stockholders’ Deficit:
Preferred stock: 10,000,000 shares authorized; $0.00001 par value; no shares issued and outstanding		—			—
Common stock: 500,000,000 shares authorized; $0.00001 par value; 425,142,610 and 421,292,610 shares issued and outstanding		4,258			4,219
Additional paid-in capital		63,954,890			63,883,853
Stock Receivable		(795,000	)		(795,000	)
Stock Payable		51,496			—
Accumulated deficit		(69,120,540	)		(68,375,078	)
Accumulated other comprehensive income		281,834			302,977
Total Stockholders’ Deficit		(5,623,062	)		(4,979,029	)

Total Liabilities and Stockholders’ Deficit	$	14,511		$	18,130

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE
INCOME

(Unaudited)


	Three Months Ending March 31,						Six Months Ending March 31,
	2024			2023			2024			2023

Revenue	$	—		$	—		$	—		$	—

Operating Expenses:
Professional Services		354,920			153,253			697,654			288,107
General and administrative		14,511			11,847			38,924			54,638
Total operating expenses		369,431			165,100			736,578			342,745

Loss from operations		(369,431	)		(165,100	)		(736,578	)		(342,745	)

Other Income (Expense):
Other income		5,800			10,662			13,840			16,962
Interest expense		(12,695	)		(5,022	)		(22,724	)		(10,135	)
Loss on extinguishment of debt		—			(40,441	)		—			(40,441	)
Total Other Income (Expense)		(6,895	)		(34,801	)		(8,884	)		(33,614	)

Net Income (Loss)	$	(376,326	)	$	(199,901	)	$	(745,462	)	$	(376,359	)

Other Comprehensive Income	$	87,987		$	16,566		$	(21,143	)	$	(57,889	)

Net Comprehensive Loss	$	(288,339	)	$	(183,335	)	$	(766,605	)	$	(434,248	)

Income (Loss) per share:
Basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)

Weighted average shares outstanding		422,939,605			374,310,750			422,879,932			374,308,086

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY

(Unaudited)

Three and Six Months Ended March 31, 2024 and 2023

															Accumulated			Total
	Common Stock				Additional		Stock			Stock		Accumulated			Comprehensive			Stockholders’
	Shares		Amount		Paid-in		Receivable			Payable		Deficit			Income			Deficit
Balance, September 30, 2023		421,292,610		4,219		63,883,853		(795,000	)		—		(68,375,078	)		302,977			(4,979,029	)
Stock Based Compensation		—		—		—		—			44,400		—			—			44,400
Debt Discount on Notes Payable		600,000		6		11,577		—			7,096		—			—			18,679
Foreign currency translation adjustment		—		—		—		—			—		—			(109,130	)		(109,130	)
Net loss		—		—		—		—			—		(369,136	)		—			(369,136	)
Balance, December 31, 2023		421,892,610		4,225		63,895,430		(795,000	)		51,496		(68,744,214	)		193,847			(5,394,216	)
Shares issued for cash		500,000		5		4,995		—			—		—			—			5,000
Stock Based Compensation		2,000,000		20		51,980		—			—		—			—			52,000
Debt Discount on Notes Payable		750,000		8		2,485		—			—		—			—			2,493
Foreign currency translation adjustment		—		—		—		—			—		—			87,987			87,987
Net loss		—		—		—		—			—		(376,326	)		—			(376,326	)
Balance, March 31, 2024		425,142,610		4,258		63,954,890		(795,000	)		51,496		(69,120,540	)		281,834			(5,623,062	)

															Accumulated			Total
	Common Stock				Additional		Stock			Stock		Accumulated			Comprehensive			Stockholders’
	Shares		Amount		Paid-in		Receivable			Payable		Deficit			Income			Deficit
Balance, September 30, 2022		374,305,480		3,748		63,527,513		(795,000	)		—		(67,070,016	)		290,563			(4,043,192	)
Foreign currency translation adjustment		—		—		—		—			—		—			(74,455	)		(74,455	)
Net loss		—		—		—		—			—		(176,458	)		—			(176,458	)
Balance, December 31, 2022		374,305,480		3,748		63,527,513		(795,000	)		—		(67,246,474	)		216,108			(4,294,105	)
Stock Based Compensation		—		—		—		—			—		—			—			—
Settlement of Notes		237,130		3		65,208		—			—		—			—			65,211
Foreign currency translation adjustment		—		—		—		—			—		—			16,566			16,566
Net loss		—		—		—		—			—		(199,901	)		—			(199,901	)
Balance, March 31, 2023		374,542,610		3,751		63,592,721		(795,000	)		—		(67,446,375	)		232,674			(4,412,229	)

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

For the Six-Month Period Ended March 31, 2024 and 2023

(Unaudited)


	2024			2023
Cash flows from operating activities
Net Income (loss)	$	(745,462	)	$	(376,359	)
Adjustments to reconcile net income/(loss) to net cash from operating activities:
Stock-based compensation		96,400			—
Depreciation expense		167			169
Amortization of intangibles		—			—
Amortization of discount		7,277			—
Loss on Settlement of Debt		—			40,441
Accounts payable related party		—			—
Impairment of assets		—			—
Change in operating assets and liabilities:
Accounts payable		181,316			88,344
Accrued interest payable		15,447			10,134
Other Receivables		4,015			(1,921	)
Pre-Payments		—			—
Due to related parties		377,000			195,304
Net cash used in operating activities		(63,840	)		(43,888	)

Cash flows from investing activities
Cash paid for purchase of fixed assets		—			—
Net cash used in investing activities		—			—

Cash flows from financing activities
Proceeds from issuance of common stock		5,000			—
Due to Affiliates		—			41,892
Issuance of convertible note – related party		59,658			—
Net cash from financing activities		64,658			41,892

Effect of currency translations to cash flow		(392	)		9,488
Net change in cash and cash equivalents		426			7,492
Beginning of period		1,094			2,857
End of period	$	1,520		$	10,349

Supplemental cash flow information	Quarter ended March 31,
	2024		2023
Interest paid	$	—	$	—
Taxes	$	—	$	—
Noncash investing and financing activities:
Settlement of Debt for Common Stock	$	—	$	24,770
Issuance of Common Stock as Debt Discount	$	21,172	$	—

The accompanying notes are an integral part of these consolidated financial statements.

GRAPHENE & SOLAR TECHNOLOGIES LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1 – BASIS OF PRESENTATION

These consolidated financial statements of Graphene & Solar Technologies Limited (GSTX or the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). In the opinion of management, these financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the results for the interim periods. Certain information, accounting policies and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to Securities and Exchange Commission (SEC) rules and regulations. These financial statements should be read along with Graphene & Solar Technologies audited financial statements as of September 30, 2023.

Going Concern – The Company has incurred cumulative net losses since inception of $69,120,540 at March 31, 2024. Accordingly, it requires capital to fund working capital deficits and for future operating activities to take place. The Company’s ability to raise new funds through the future issuances of debt or common stock is unknown. The obtainment of additional financing, the successful development of a plan of operations, and its transition, ultimately, to the attainment of profitable operations are necessary for the Company to continue operations. The ability of the Company to continue its operations is dependent on management’s plans, which include the raising of capital through debt and/or equity markets, with some additional funding from other traditional financing sources, including term notes, until such time that funds provided by operations are sufficient to fund working capital requirements. The Company may need to incur additional liabilities with certain related parties to sustain the Company’s existence. There can be no assurance that the Company will be able to raise any additional capital and therefore raise doubt about the Company’s ability to continue as a going concern.

Future issuances of the Company’s equity or debt securities will be required for the Company to finance operations and continue as a going concern. The financial statements do not include any adjustments that may result from the outcome of these uncertainties.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2023.

Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment, and the liquidation of liabilities.

Cash and Cash Equivalents – Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2024 and 2023, the Company had $1,520 and $10,349 in cash, respectively, and no cash equivalents.

Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations.

The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows.

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

There was no derivative activity in fiscal quarter ending March 31, 2024. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2024.

Stock-Based Compensation – ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period).

During the quarter ended March 31, 2024, the Company issued 3,250,000 shares of the Company’s common stock.

Total stock-based compensation expense was $96,400 for the six-months ended March 31, 2024.

Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.

Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.

Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

NOTE 3 – NOTES PAYABLE

The Company’s indebtedness as of March 31, 2024 and September 30, 2023 were as follows:

Schedule of notes payable


Description	March 31, 2024		September 30, 2023

Convertible notes	$	100,747	$	100,747
Convertible notes – related party, net of discount $13,895		63,933		—
Notes Payable	$	60,000	$	60,000
Notes Payable – Related Parties	$	53,543	$	71,713

Notes Payable and Other Loans

During 2015 and 2016, the Company executed promissory notes payable with six individuals with an aggregate principal balance of $60,000. The notes were due on demand and included interest at 10%. As of March 31, 2024 and September 30, 2023, the total promissory notes payable balance was $111,718 and $108,710 including accrued interest of $51,718 and $48,710, respectively. On January 15, 2019, the holder of a note with a principal balance of $10,000 made demand for payment. To date, the note has not been paid.

During the year ended September 30, 2020 a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

Convertible Notes Payable

As of March 31, 2024 and September 30, 2023, noteholders representing $70,747 in outstanding principal had not requested the exchange of shares of common stock. As of March 31, 2024 and September 30, 2023, the exchange obligation payable was $184,830 and $179,510 including accrued interest of $114,083 and $108,762, respectively. As of March 31, 2024 and September 30, 2023, the exchange obligation was for 55,840 shares and 54,233 shares of common stock, respectively.

On February 1, 2016, the Company issued convertible secured note payable of $30,000 to an individual. The note was due on January 31, 2017 and included interest at 10%. The note was convertible at discretion of the holder into common shares of the Company at the rate of $0.50 per shares. The Company has not extended the maturity date and the note is in default. As of March 31, 2024 and September 30, 2023, the total convertible note payable balance was $54,501 and $52,997, including accrued interest of $24,501 and $22,997 respectively. As of March 31, 2024 and September 30, 2023, the exchange obligation was for 109,002 shares and 105,994 shares of common stock, respectively.

Convertible Notes Payable – Related Party

During the quarter ended December 31, 2023, the Company entered into an agreement to issue convertible notes payable with an accredited investor. Notably, there exists a professional relationship between the Company and the investor, facilitated by a mutual director serving on the boards of both entities. These notes carry an aggregate principal balance of $50,000 and accrue interest at a rate of 10% per annum. Their maturity dates are set for October 2024 and December 2024. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of March 31, 2024, the total balance of promissory notes payable stood at $51,952, inclusive of accrued interest totaling $1,952. Moreover, the exchange obligation associated with these notes amounted to 519,520 shares of common stock. In return for providing the loan, the Company authorized the issuance of 1,000,000 shares of common stock to the lender. By the end of March 31, 2024, 600,000 shares had been issued, leaving 400,000 shares unissued – see NOTE 8. The Company recorded an initial debt discount of $18,679 upon the issuance of the notes, with subsequent amortization of debt discount totaling $7,217.

During the quarter ended March 31, 2024, the Company entered into agreements to issue a convertible notes payable with a director serving on the board. The notes carry an aggregate principal balance of $27,828 and accrue interest at a rate of 10% per annum. Their maturity dates are set for March 2025. Additionally, the notes offer the option for conversion into common shares of the Company at the discretion of the holder, with a conversion rate of $0.10 per share. As of March 31, 2024, the total balance of promissory notes payable stood at $29,300, inclusive of accrued interest totaling $1,472. Moreover, the exchange obligation associated with these notes amounted to 293,000 shares of common stock. In return for providing the loan, the Company authorized the issuance of 500,000 shares of common stock to the lender. By the end of March 31, 2024, 500,000 shares had been issued. The Company recorded an initial debt discount of $2,493 upon the issuance of the notes, with subsequent amortization of debt discount totaling $60.

Related Party Loans

On December 5, 2022, the Company entered into a Promissory Loan Note with Mr. Andrew Liang, in the amount of US$20,000, with a maturity date of December 5, 2023. The loan will accrue interest at the rate of 10% per annum.

On February 28, 2023, the Company entered into a Promissory Loan Note with MI Labs Pty Ltd, in the amount of US$50,000 (of which $31,943 was received by the company as of March 31, 2024) with a maturity date of February 28, 2024. The loan will accrue interest at the rate 10% per annum.

NOTE 4 – RELATED PARTY

MI Labs Pty Ltd, a management company controlled by Mr. Jason May, the Company’s Chief Executive Officer and a Company Director, provides management services to the Company for which the Company is charged $25,000 monthly. During the three months ended March 31, 2024, the Company incurred charges to operations of $75,000 with respect to this arrangement.

CSA Liang Pty Ltd, a management company controlled by Mr. Andrew Liang, a Company Director, provided corporate advisor services to the Company for which the Company was charged $5,000 monthly. During the three months ended March 31, 2024, the Company incurred charges to operations of $15,000 with respect to this arrangement.

Sativus Investments, a management company controlled by Mr. Paul Saffron, the Company’s Chief Operations Officer, provides management services to the Company for which the Company is charged $20,000 monthly. During the three months ended March 31, 2024, the Company incurred charges to operations of $60,000 with respect to this arrangement.

Pagemark Limited, a management company controlled by Mr. David Halstead, a Company Director, entered into a convertible note agreement with the Company – see NOTE 3.

Allegro Investments Limited entered into a convertible note agreement with the Company. The Company and Allegro Investments Limited share a professional relationship wherein a director serves on the boards of both entities – see NOTE 3.

During the quarters ended March 31, 2024 and 2023, stock-based compensation expense relating to directors, officers, affiliates and related parties was $52,000 (2,000,000 shares) and $0 (no shares), respectively.

NOTE 5 – STOCKHOLDERS’ EQUITY

3,850,000 new common shares were issued during the six- month period ending March 31, 2024. The Company has a total of 5,778,367 shares that remain approved, reserved and outstanding and not yet issued by the Transfer Agent at March 31, 2024.

Mr. Jason May was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Paul Saffron was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Ms. Kristine Woo was granted 2,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued.

NOTE 6 – COMMITMENTS & CONTINGENCIES

Contingencies

From time to time, we may be involved in routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. The ultimate amount of liability, if any, for any claims of any type (either alone or in the aggregate) may materially and adversely affect our financial condition, results of operations and liquidity. In addition, the ultimate outcome of any litigation is uncertain. Any outcome, whether favorable or unfavorable, may materially and adversely affect us due to legal costs and expenses, diversion of management attention and other factors. We expense legal costs in the period incurred. We cannot assure you that additional contingencies of a legal nature or contingencies having legal aspects will not be asserted against us in the future, and these matters could relate to prior, current or future transactions or events. As of March 31, 2024, there were no pending or threatened litigation against the Company.

NOTE 7 – INTANGIBLE ASSETS/PATENTS

We amortize capitalized patent costs for internally generated patents on a straight-line basis for 7 years, which represents the estimated useful lives of the patents. The seven-year estimated useful life for internally generated patents is based on our assessment of such factors as: the integrated nature of the portfolios being licensed, the overall makeup of the portfolio over time, and the length of license agreements for such patents. The estimated useful lives of acquired patents and patent rights, however, have been and will continue to be based on a separate analysis related to each acquisition and may differ from the estimated useful lives of internally generated patents. The average estimated useful life of acquired patents is 6.7 years. We assess the potential impairment to all capitalized net patent costs when events or changes in circumstances indicate that the carrying amount of our patent portfolio may not be recoverable.

Components of intangible assets are as follows:


	March 30, 2024		March 30, 2023
Patents		1		1
Accumulated amortization		—		—
Total patent costs, net		1		1

NOTE 8 – SUBSEQUENT EVENTS

On July 28, 2023, Mr. Juan Hilsaca signed a consulting agreement with the Company and was granted 250,000 shares. The Company issued 250,000 shares on April 12, 2024, per the terms of the agreement.

On December 13, 2023, the Company entered into an agreement to issue a convertible note payable with an accredited investor. Per the terms of the agreement, the lender was granted 1,000,000 shares. 600,000 shares were issued in the previous quarter – see NOTE 3. The remaining 400,000 shares were issued on April 25, 2024.

Mr. Jason May was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Paul Saffron was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Ms. Kristine Woo was granted 2,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Thomas Chang was granted a maximum of 1,000,000 shares per annum subject to performance in fiscal years 2021/2022, 2022/2023 and 2023/2024 to a total of 3,000,000 shares. 1,000,000 shares were issued during the 2021/2022 fiscal year. As of this filing date, the remaining 2,000,000 shares have been approved but remain unissued.

The Company has evaluated events occurring subsequent to March 31, 2024 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND PLAN OF OPERATION

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information included in this Form 10-Q.

Our Management’s Discussion and Analysis contains not only statements that are historical facts, but also statements that are forward-looking. Forward-looking statements are, by their very nature, uncertain and risky. Although the forward-looking statements in this Quarterly Report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by them. Consequently, and because forward-looking statements are inherently subject to risks and uncertainties, the actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. You are urged to carefully review and consider the various disclosures made by us in this report as we attempt to advise interested parties of the risks and factors that may affect our business, financial condition, and results of operations and prospects.

FORWARD LOOKING STATEMENTS

The information contained in this Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including among other things, statements regarding our capital needs, business strategy and expectations. Any statement which does not contain a historical fact may be deemed to be a forward-looking statement. In some cases, you can identify forward-looking statements by terminology such as “may”, “will”, “should”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential” or “continue”, the negative of such terms or other comparable terminology. In evaluating forward looking statements, you should consider various factors outlined in our Form 10-K report for the year ended September 30, 2023, filed with the U.S. Securities Exchange Commission (“SEC”) and, from time to time, in other reports we file with the SEC. These factors may cause our actual results to differ materially from any forward-looking statement. We disclaim any obligation to publicly update these statements or disclose any difference between our actual results and those reflected in these statements.

Overview

We are primarily focused on providing the materials and technologies for a greener future. GSTX has a portfolio of projects in the cleantech are with:

•

Patented and novel technologies.

•

Proven products with exclusive geographical distribution rights.

•

Ground-breaking new innovations.

•

Mineral resources that critical to the high-tech supply chain.

These investments focus on global opportunities, multi-billion-dollar industries, with a significant positive environmental impact. GSTX is focused on projects with exceptionally strong business opportunities, taking advantage of the environmental and supply chain challenges the world faces at present. GSTX is currently focused on supplying advanced materials to existing manufacturers and water harvesting products to market.

Advanced Materials

A portfolio of proprietary technologies for upstream manufacturing material supply into high tech markets including solar, semiconductor, defense.

•

The Dragonfly range of transparent conductive thin films.

•

High purity quartz sand production.

•

High purity graphite production.

Water Technologies

A portfolio of products and technologies for providing clean drinkable water for consumers and industry.

•

Ambient water harvesting equipment.

•

The company is also exploring opportunities in water remediation, oils spill clean-up.

The Company is also exploring acquisition opportunities for Critical Resources Assets (Minerals with identified supply chain risk), zero emission fossil fuel replacement, green hydrogen, and ammonia production.

Operational Overview.

US Thin Films

US Thin-Film Corporation, a 100% owned subsidiary of GSTX holds a Patent Portfolio (IP) relating to the novel leading-edge production of conductive transparent thin films. The thin films are based on a conductive nanoparticle technology, an innovative conductive coating that self-assembles into a random mesh-like network pattern when coated, providing excellent electrical conductivity, high transparency, and flexibility. The Technology was founded and developed in Israel and has built up significant R&D profile for over 15 years with more than USD $90 Million invested. The technology has won several international touchscreen technology awards.

Applications of the proprietary thin film in existing electronics applications outperforms current materials. Key applications include: Electromagnetic Interference (EMI) Shielding, Flexible Transparent Antennas (4G/5G communications), Transparent Heaters (windows, goggles, etc), Touch Displays (monitors, phones, tablets), Photovoltaic, OLED Lighting, Flexible Displays, Sensors, and numerous other electronic applications

The US Thin-Film technology is superior to traditional/existing technology with multiple times the electrical conductivity of conventional ITO based transparent conductive films with a simple manufacturing method protected by the company’s patent portfolio.

The company is presently in discussions with several contract manufacturing groups to produce initial samples of its thin film technology, branded Dragonfly film, for product qualification and pre-sales activity purposes.

Water Harvesting

Water scarcity is at the center of the world’s most significant challenges. The United Nations estimates approximately 30% of the world’s population will face severe water shortages by 2025. Many people do not realise that the atmosphere, the air we breathe, contains a significant amount of water. Humidity is water in the air. Air can hold 1-2 ounces of water per cubic yard. At any one instant, the Earth’s atmosphere contains 37.5 trillion gallons of water vapor – enough to cover the entire surface of the planet with 1.5 inches of rain if condensed.

In parallel, massive population growth and urbanisation has led to an unprecedented demand for fresh water. Investment in infrastructure has been woefully inadequate, resulting in severe and critical water stress globally.

There are an estimated 13 trillion litres (3.4 trillion gal) of water floating in the atmosphere at any one time. There is 6 times as much fresh water in the air as in all rivers and lakes in the world.

The Company is continuing commercialization of a unique water harvesting technology utilizing modular, self-contained units that can be solar or grid powered, and deployed in urban and rural environments. The water harvesters will extract moisture from the ambient air and lect as 100% pure fresh water. Each domestic water harvester will be capable of generating 30-50 liters (8-13 gal) of pure fresh water per day for personal use, with commercial models lecting up to 50,000 liters (13,000 gal) per day. The 100% pure H20 extracted from the atmosphere is also suitable for industrial use in green hydrogen production and pharmaceutical, semiconductor processing plants.

A 100% operational subsidiary has been established for the water harvesting products. It will trade as Adaquo, which is a Latin verb meaning to supply water. The company has engaged the services of two industry veterans (20+ years experience) to assist with commercialization of the technology.

Whilst still undertaking in house development of the company’s proprietary solid-state technology, the company is also exploring opportunities to license and distribute existing products that have been market proven on an exclusive geographical basis.

Quartz Material.

The company has significant technical expertise and experience in the high purity quartz sector. Initially, the company focused upon acquiring resources and developing high purity silica (99.9% purity) into commercial grade high purity quartz sand (HPQS 99.997% purity). HPQS is essential for the production of semiconductors and photovoltaic solar panels.

Although the enterprise was successful in identifying substantial resources and valuable customers in Japan, China, South Korea, Taiwan and South-East Asia, the company was unable to secure funding to scale to meet demand for HPQS product, largely due to complications with the onset of Covid-19 in March 2020. The COVID Pandemic saw significant disruption to the global solar and semiconductor manufacturing sector. This had significant flow on effects to HPQS market. It is anticipated that by mid-2023 the sector will be substantially recovered to pre-covid levels of production and associated demand for raw materials. At present manufacturing levels of solar cells are showing strong growth and a swift recovery.

The company is presently re-engaging with past acquisition opportunities and customers in the HPQ sector. At present there is a significant production shortfall for the material and prices/volumes are showing strong growth. The company is continuing to pursue the development of an Australian based production facility.

Graphene Material.

Graphene, a new material, was discovered in 2004 by two UK based Russian university professors who were awarded the Nobel Prize in 2010 for their discovery. Graphene is a 2D material, (one atom thickness) made from graphite/carbon atoms, and whilst still largely unknown to the world is rapidly becoming a new industrial revolution in its own right with more than 8,800 patent applications for graphene and graphene enabled product applications having been filed recently. We have taken an early-stage leading-edge position in this evolving new technological field of graphene enabling and enhancement, specifically to focus upon development of graphene enabled photovoltaic solar panels.

Graphene is the world’s thinnest and strongest material ever, with remarkable electrical, thermal, and optical properties being the most conductive material ever scientifically measured. A sheet of graphene material is only one single atom in thickness and is referred to as a 2D nano-material having almost no measurable depth, only length and width. Graphene is also highly transparent and can be easily flexed and stretched 25% of its size without breaking. However, it is also 200 times stronger than steel and harder than a diamond. Graphene material is completely impermeable, even a helium atom (the smallest) cannot pass through graphene. The advent of graphene and the introduction of the extraordinary benefits from combining graphene with existing materials and products.

Our main focus remains dedicated to our original premise of producing low cost, high grade, high purity graphene for industrial sales to existing materials groups.

Results of Operations

For the fiscal quarters ended March 31, 2024 and 2023, we generated no revenues, and thus no cost of sales or gross profits.

For the fiscal quarter ended March 31, 2024 and 2023, we incurred $369,431 and $165,100 respectively in operating expenses.

For the fiscal quarter ended March 31, 2024 we recorded other expenses of $12,695, while in the fiscal quarter ended March 31, 2023, we incurred expenses of $45,463; both items are represented by accrued interest on debt.

For the fiscal quarter ended March 31, 2024, we recorded other income of $5,800, while in the fiscal quarter ended March 31, 2023, we recorded other income of $10,662.

For the fiscal quarter ended March 31, 2024, $0 was recognized as loss on extinguishment of debt, while in the fiscal quarter ended March 31, 2023 we recorded $40,441.

For the six months ended March 31, 2024, we reported net loss before taxes of $745,462, while in the six months ended March 31, 2023, we reported a net loss before taxes of $376,359. Since there were no tax obligations in either year, net income / loss in each year was the same as that reported before taxes.

For the periods ended September 30, 2023 and March 31, 2024, our cash positions were $1,094 and $1,520, respectively.

As of March 31, 2024, we had total current liabilities of $5,637,573 while as of September 30, 2023, we had total current liabilities of $4,997,159 an increase of about 11%. Accrued interest payable increased from $184,851 to $200,298, all attributable to accruals on the loans and the convertible notes payable.

Liquidity and Capital Resources

As of March 31, 2024, we had $12,755 in total current assets and $5,637,573 in total current liabilities. Accordingly, we had a working capital deficit of $5,624,818.

Cash used in operating activities was $63,840 for the six months ended March 31, 2024, as compared to $43,888 cash used in operating activities for the six months ended March 31, 2023.

Net cash provided by financing activities was $64,658 for the six months ended March 31, 2024, as compared to $41,892 for the quarter ended March 31, 2023.

Off-Balance Sheet Arrangements

There are no off-balance sheet arrangements.

Critical Accounting Policies and Estimates

For a discussion of our accounting policies and related items, please see the Notes to the Financial Statements, included in Item 1.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

An evaluation was carried out under the supervision and with the participation of our management, including our Principal Executive and Interim Financial Officer, of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report on Form 10-Q. Disclosure controls and procedures are procedures designed with the objective of ensuring that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, such as this Form 10-Q, is recorded, processed, summarized and reported, within the time period specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and is communicated to our management, including our Principal Executive [and Financial Officer], or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our management concluded that, as of December 31, 2020, our disclosure controls and procedures were not effective.

Management conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2020, based on the framework established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013 (“COSO”).

As of period covered by this Quarterly Report on Form 10-Q, we have concluded that our internal control over financial reporting was ineffective. The Company’s assessment identified certain material weaknesses which are set forth below:

Functional Controls and Segregation of Duties

Because of the Company’s limited resources, there are limited controls over information processing.

There is an inadequate segregation of duties consistent with control objectives. Our Company’s management is composed of a small number of individuals resulting in a situation where limitations on segregation of duties exist. In order to remedy this situation, we would need to hire additional staff to provide greater segregation of duties. Currently, it is not feasible to hire additional staff to obtain optimal segregation of duties. Management will reassess this matter in the following year to determine whether improvement in segregation of duty is feasible.

Accordingly, as the result of identifying the above material weakness we have concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the Company’s internal controls.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting and for the assessment of the effectiveness of internal control over financial reporting. As defined by the Securities and Exchange Commission, internal control over financial reporting is a process designed by, or under the supervision of our Principal Executive and Financial Officer and implemented by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements in accordance with U.S. generally accepted accounting principles.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Roger May, our previous Principal Executive Officer, evaluated the effectiveness of our internal control over financial reporting as of December 31, 2020 based on criteria established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, or the COSO Framework (2013). Management’s assessment included an evaluation of the design of our internal control over financial reporting and testing of the operational effectiveness of those controls.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Management has addressed the underlying causes for our weaknesses in internal control since early FY 2020. Our efforts to raise both debt and equity capital soon will allow us to undertake additional engagement of external independent consultants to assist with the processing of data and drafting financial reports on a timely basis in future reporting periods.

PART II

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

Our business is subject to numerous risks and uncertainties including but not limited to those discussed in “Risk Factors” in our annual report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Please see Note 5 to our Financial Statements.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibits

31.1	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification pursuant to Section 906 of the Sarbanes-Oxley Act.

32.2	Certification pursuant to Section 906 of the Sarbanes-Oxley Act.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	GRAPHENE & SOLAR TECHNOLOGIES LIMITED

Date: May 24, 2024	By:	/s/ Jason May
		Chief Executive Officer and Director

EXHIBIT 31.1

CERTIFICATIONS

I, Jason May, certify that;

1.	I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;

2.	Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 24, 2024	By:	/s/ Jason May
		Jason May
		Chief Executive Officer and Director

EXHIBIT 31.2

CERTIFICATIONS

I, David AB Halstead, certify that;

1.	I have reviewed this quarterly report on Form 10-Q of Graphene & Solar Technologies Limited;

2.	Based on my knowledge, this report, does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by the report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 24, 2024	By:	/s/ David AB Halstead
		David AB Halstead Chief Financial Officer and Director

EXHIBIT 32.1

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), Jason May, the Chief Executive Officer and Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

Date: May 24, 2024	By:	/s/ Jason May
		Jason May
		Chief Executive Officer and Director

EXHIBIT 32.2

In connection with the Quarterly Report of Graphene & Solar Technologies Limited (the “Company”) on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission (the “Report”), David A.B. Halstead, the Chief Financial Officer and Director of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	The information contained in the Report fairly presents, in all material respects the financial condition and results of operations of the Company.

Date: May 24, 2024	By:	/s/ David Halstead
		David Halstead,
		Chief Financial Officer and Director

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 23, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--09-30
Entity File Number	333-174194
Entity Registrant Name	GRAPHENE & SOLAR TECHNOLOGIES LTD
Entity Central Index Key	0001497649
Entity Tax Identification Number	27-2888719
Entity Incorporation, State or Country Code	CO
Entity Address, Address Line One	11201 North Tatum Blvd.
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85028
City Area Code	602
Local Phone Number	388-8335
Entity Current Reporting Status	Yes
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		425,792,610

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Sep. 30, 2023
Current Assets:
Cash	$ 1,520	$ 1,094
Prepaid expenses	11,235	11,108
Total Current Assets	12,755	12,202
Other Assets:
Furniture and equipment, net of depreciation $78,106	780	937
Intellectual property – at cost, net	1	1
Other intangible assets – at cost	975	975
Other receivable		4,015
Total Assets	14,511	18,130
Current Liabilities:
Accounts payable and other payable	2,782,472	2,594,247
Accrued interest payable	200,298	184,851
Due to related party	2,376,580	1,985,601
Notes payable, $60,000 in default	60,000	60,000
Notes payable – related party	53,543	71,713
Convertible notes payable, $100,747 in default	100,747	100,747
Convertible notes payable – related party, net of discount $13,895 and $0	63,933
Total Current Liabilities	5,637,573	4,997,159
Total Liabilities	5,637,573	4,997,159
Preferred stock: 10,000,000 shares authorized; $0.00001 par value; no shares issued and outstanding
Common stock: 500,000,000 shares authorized; $0.00001 par value; 425,142,610 and 421,292,610 shares issued and outstanding	4,258	4,219
Additional paid-in capital	63,954,890	63,883,853
Stock Receivable	(795,000)	(795,000)
Accumulated deficit	(69,120,540)	(68,375,078)
Accumulated other comprehensive income	281,834	302,977
Total Stockholders’ Deficit	(5,623,062)	(4,979,029)
Total Liabilities and Stockholders’ Deficit	$ 14,511	$ 18,130

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2024	Sep. 30, 2023
Statement of Financial Position [Abstract]
Furniture and equipment, net of depreciation	$ 78,106
Debt Instrument, Unamortized Discount, Current	$ 13,895	$ 0
Preferred stock, authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Common stock, authorized	500,000,000	500,000,000
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, issued	425,142,610	421,292,610
Common stock, outstanding	425,142,610	421,292,610

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue
Operating Expenses:
Professional Services	354,920	153,253	697,654	288,107
General and administrative	14,511	11,847	38,924	54,638
Total operating expenses	369,431	165,100	736,578	342,745
Loss from operations	(369,431)	(165,100)	(736,578)	(342,745)
Other Income (Expense):
Other income	5,800	10,662	13,840	16,962
Interest expense	(12,695)	(5,022)	(22,724)	(10,135)
Loss on extinguishment of debt		(40,441)		(40,441)
Total Other Income (Expense)	(6,895)	(34,801)	(8,884)	(33,614)
Net Income (Loss)	(376,326)	(199,901)	(745,462)	(376,359)
Other Comprehensive Income
Net Comprehensive Loss	$ (288,339)	$ (183,335)	$ (766,605)	$ (434,248)
Income (Loss) per share:
Basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average shares outstanding	422,939,605	374,310,750	422,879,932	374,308,086

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIENCY - USD ($)	3 Months Ended				6 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023
Balance, December 31, 2022	$ (5,394,216)	$ (4,979,029)	$ (4,294,105)	$ (4,043,192)	$ (4,979,029)	$ (4,043,192)
Stock Based Compensation	52,000	44,400
Debt Discount on Notes Payable	2,493	18,679
Foreign currency translation adjustment	87,987	(109,130)	16,566	(74,455)
Net loss	(376,326)	(369,136)	(199,901)	(176,458)	(745,462)	(376,359)
Shares issued for cash	5,000
Balance, March 31, 2023	(5,623,062)	(5,394,216)	(4,412,229)	(4,294,105)	(5,623,062)	(4,412,229)
Settlement of Notes			65,211
Common Stock [Member]
Balance, December 31, 2022	$ 4,225	$ 4,219	$ 3,748	$ 3,748	$ 4,219	$ 3,748
Balance, shares	421,892,610	421,292,610	374,305,480	374,305,480	421,292,610	374,305,480
Stock Based Compensation	$ 20
Debt Discount on Notes Payable	8	6
Balance, shares	750,000	600,000
Foreign currency translation adjustment
Net loss
Shares issued for cash	$ 5
Shares issued for cash, shares	500,000
Stock-based compensation, shares	2,000,000
Balance, March 31, 2023	$ 4,258	$ 4,225	$ 3,751	$ 3,748	$ 4,258	$ 3,751
Balance, shares	425,142,610	421,892,610	374,542,610	374,305,480	425,142,610	374,542,610
Settlement of Notes			$ 3
Settlement of notes			237,130
Additional Paid-in Capital [Member]
Balance, December 31, 2022	$ 63,895,430	$ 63,883,853	$ 63,527,513	$ 63,527,513	$ 63,883,853	$ 63,527,513
Stock Based Compensation	51,980
Debt Discount on Notes Payable	2,485	11,577
Foreign currency translation adjustment
Net loss
Shares issued for cash	4,995
Balance, March 31, 2023	63,954,890	63,895,430	63,592,721	63,527,513	63,954,890	63,592,721
Settlement of Notes			65,208
Stock Receivable [Member]
Balance, December 31, 2022	(795,000)	(795,000)	(795,000)	(795,000)	(795,000)	(795,000)
Stock Based Compensation
Debt Discount on Notes Payable
Foreign currency translation adjustment
Net loss
Shares issued for cash
Balance, March 31, 2023	(795,000)	(795,000)	(795,000)	(795,000)	(795,000)	(795,000)
Settlement of Notes
Stock Payable [Member]
Balance, December 31, 2022	51,496
Stock Based Compensation		44,400
Debt Discount on Notes Payable		7,096
Foreign currency translation adjustment
Net loss
Shares issued for cash
Balance, March 31, 2023	51,496	51,496			51,496
Settlement of Notes
Retained Earnings [Member]
Balance, December 31, 2022	(68,744,214)	(68,375,078)	(67,246,474)	(67,070,016)	(68,375,078)	(67,070,016)
Stock Based Compensation
Debt Discount on Notes Payable
Foreign currency translation adjustment
Net loss	(376,326)	(369,136)	(199,901)	(176,458)
Shares issued for cash
Balance, March 31, 2023	(69,120,540)	(68,744,214)	(67,446,375)	(67,246,474)	(69,120,540)	(67,446,375)
Settlement of Notes
AOCI Attributable to Parent [Member]
Balance, December 31, 2022	193,847	302,977	216,108	290,563	302,977	290,563
Stock Based Compensation
Debt Discount on Notes Payable
Foreign currency translation adjustment	87,987	(109,130)	16,566	(74,455)
Net loss
Shares issued for cash
Balance, March 31, 2023	$ 281,834	$ 193,847	232,674	$ 216,108	$ 281,834	$ 232,674
Settlement of Notes

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net Income (loss)	$ (745,462)	$ (376,359)
Adjustments to reconcile net income/(loss) to net cash from operating activities:
Stock-based compensation	96,400
Depreciation expense	167	169
Amortization of intangibles
Amortization of discount	7,277
Loss on Settlement of Debt		40,441
Accounts payable related party
Impairment of assets
Change in operating assets and liabilities:
Accounts payable	181,316	88,344
Accrued interest payable	15,447	10,134
Other Receivables	4,015	(1,921)
Pre-Payments
Due to related parties	377,000	195,304
Net cash used in operating activities	(63,840)	(43,888)
Cash paid for purchase of fixed assets
Net cash used in investing activities
Cash flows from financing activities
Proceeds from issuance of common stock	5,000
Due to Affiliates		41,892
Issuance of convertible note – related party	59,658
Net cash from financing activities	64,658	41,892
Effect of currency translations to cash flow	(392)	9,488
Net change in cash and cash equivalents	426	7,492
Beginning of period	1,094	2,857
End of period	1,520	10,349
Supplemental cash flow information
Taxes
Noncash investing and financing activities:
Settlement of Debt for Common Stock		24,770
Issuance of Common Stock as Debt Discount	$ 21,172

BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION

At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital.

There was no derivative activity in fiscal quarter ending March 31, 2024. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2024.

During the quarter ended March 31, 2024, the Company issued 3,250,000 shares of the Company’s common stock.

Total stock-based compensation expense was $96,400 for the six-months ended March 31, 2024.

NOTES PAYABLE

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

The Company’s indebtedness as of March 31, 2024 and September 30, 2023 were as follows:

Schedule of notes payable


Description	March 31, 2024		September 30, 2023

Convertible notes	$	100,747	$	100,747
Convertible notes – related party, net of discount $13,895		63,933		—
Notes Payable	$	60,000	$	60,000
Notes Payable – Related Parties	$	53,543	$	71,713

Notes Payable and Other Loans

During the year ended September 30, 2020 a Company Advisor, loaned the Company $5,781. The loan is a demand note at zero interest.

Convertible Notes Payable

Convertible Notes Payable – Related Party

Related Party Loans

RELATED PARTY

3 Months Ended

Mar. 31, 2024

RELATED PARTY

NOTE 4 – RELATED PARTY

Pagemark Limited, a management company controlled by Mr. David Halstead, a Company Director, entered into a convertible note agreement with the Company – see NOTE 3.

STOCKHOLDERS’ EQUITY

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 5 – STOCKHOLDERS’ EQUITY

Mr. Jason May was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Paul Saffron was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Ms. Kristine Woo was granted 2,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued.

COMMITMENTS & CONTINGENCIES

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS & CONTINGENCIES

NOTE 6 – COMMITMENTS & CONTINGENCIES

Contingencies

INTANGIBLE ASSETS/PATENTS

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS/PATENTS

NOTE 7 – INTANGIBLE ASSETS/PATENTS

Components of intangible assets are as follows:


	March 30, 2024		March 30, 2023
Patents		1		1
Accumulated amortization		—		—
Total patent costs, net		1		1

SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2024

Subsequent Events

SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS

On July 28, 2023, Mr. Juan Hilsaca signed a consulting agreement with the Company and was granted 250,000 shares. The Company issued 250,000 shares on April 12, 2024, per the terms of the agreement.

Mr. Jason May was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Mr. Paul Saffron was granted 2,000,000 shares per annum, per the terms of his consulting agreement. As of this filing date, the shares have been approved but remain unissued.

Ms. Kristine Woo was granted 2,000,000 shares per annum, per the terms of her consulting agreement. As of this filing date, the shares have been approved but remain unissued.

The Company has evaluated events occurring subsequent to March 31, 2024 through to the date these financial statements were issued and has identified no additional events requiring disclosure.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND BASIS OF PRESENTATION (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation — The consolidated financial statements include the accounts of Graphene & Solar Technologies Limited and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). A summary of the significant accounting policies applied in the preparation of the accompanying financial statements can be found in the Company’s Annual Report in form 10-K for the year ended September 30, 2023.
Use of Estimates	Use of Estimates - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment, and the liquidation of liabilities. Cash and Cash Equivalents – Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments. As of March 31, 2024 and 2023, the Company had $1,520 and $10,349 in cash, respectively, and no cash equivalents.
Derivative Financial Instruments	Derivative Financial Instruments – The Company accounts for freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument or generally as a liability. A contract so designated is carried at fair value on a company’s balance sheet, with any changes in fair value recorded as a gain or loss in a company’s results of operations. The Company records all derivatives on the balance sheet at fair value, adjusted at the end of each reporting period to reflect any material changes in fair value, with any such changes classified as changes in derivatives valuation in the statement of operations. The calculation of the fair value of derivatives utilizes highly subjective and theoretical assumptions that can materially affect fair values from period to period. The recognition of these derivative amounts does not have any impact on cash flows. At the date of the conversion of any convertible debt, the pro rata fair value of the related embedded derivative liability is transferred to additional paid-in capital. There was no derivative activity in fiscal quarter ending March 31, 2024. Therefore, no derivative liabilities were recorded during the quarter ended March 31, 2024.
Stock-Based Compensation	Stock-Based Compensation – ASC 718, “Compensation - Stock Compensation,” prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees and non-employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on their fair values on the grant date. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). During the quarter ended March 31, 2024, the Company issued 3,250,000 shares of the Company’s common stock. Total stock-based compensation expense was $96,400 for the six-months ended March 31, 2024.
Foreign Currency Translations	Foreign Currency Translations – The functional currency of the Company’s foreign subsidiary is primarily the respective local currency. Assets and liabilities of the Company’s foreign subsidiary are translated into U.S. Dollars at the year-end exchange rate, and revenues and expenses are translated at average monthly exchange rates. Translation gains and losses are recorded as a component of accumulated other comprehensive income (loss) within stockholders’ equity. All other foreign currency transaction gains and losses are included in other (income) expense, net.
Earnings Per Share	Earnings Per Share - Basic earnings per share have been calculated based upon the weighted-average number of common shares outstanding. Diluted earnings per share were not calculated as such potential shares would be anti-dilutive.
Reclassifications	Reclassifications - Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.

NOTES PAYABLE (Tables)

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Schedule of notes payable


Description	March 31, 2024		September 30, 2023

Convertible notes	$	100,747	$	100,747
Convertible notes – related party, net of discount $13,895		63,933		—
Notes Payable	$	60,000	$	60,000
Notes Payable – Related Parties	$	53,543	$	71,713

INTANGIBLE ASSETS/PATENTS (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of finite lived intangible assets


	March 30, 2024		March 30, 2023
Patents		1		1
Accumulated amortization		—		—
Total patent costs, net		1		1

NOTES PAYABLE (Details) - USD ($)	Mar. 31, 2024	Sep. 30, 2023
Debt Disclosure [Abstract]
Convertible notes	$ 100,747	$ 100,747
Convertible notes – related party, net of discount $13,895	63,933
Notes Payable	60,000	60,000
Notes Payable – Related Parties	$ 53,543	$ 71,713